India pharma gives thumbs up for Union Budget’s Manufacturing Mission and classification of MSME criteria. Considerable attention to MSME sector is lauded. The Manufacturing Mission Furthering Make in ...

In a significant policy shift, the Directorate General of Foreign Trade (DGFT), under the ministry of commerce and industry, has announced the withdrawal of Para 2.76 of the Handbook of Procedures ...

Celltrion, a leading biopharmaceutical company based in Incheon, South Korea, announced that the US Food and Drug Administration (FDA) has approved Avtozma (CT-P47, tocilizumab-anoh) in both an ...

Indian healthcare industry is increasingly paving the way for resilient and responsive medical delivery system. With a growing population, rising disease burden, and an insufficient number of ...

The Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA) has noted a mixed reaction to the Union Budget 2025. The only silver lining is that the lower and middle income groups will ...

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced that the European Commission has authorised ...

Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies, ...

Enveric Biosciences, a Naples-headquartered biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and ...

As global trade and e-commerce are expected to expand rapidly in 2025, the need for robust traceability and authentication solutions has become critical. Counterfeiting, product diversion, and ...

Merck, known as MSD outside of the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of ...

Onco-Innovations Limited, a Canadian-based company dedicated to cancer research and treatment, specializing in oncology, has provided information on its licensed technology of a new class of PNKP ...

Chugai Pharmaceutical Co., Ltd. announced that it signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for the development of an anti-dengue virus antibody. Under this agreement, ...